We unpack the full scope of the U.S. budget cuts, from canceled clinical trials and stalled drug approvals to mass layoffs ...

The antibody discovery landscape is at a turning point. As the demand for more effective and targeted therapeutics grows to tackle challenging targets, traditional methods—focused on binding rather ...

Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in ...

Find out how you can mitigate risks when expanding your biotech business internationally in the current tariff and trade ...

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Learn about metabolomics, biology's fourth language that has remained vastly untapped up until now and could accelerate ...

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.